| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...863303R |
| P356 | DOI | 10.1371/JOURNAL.PONE.0063303 |
| P932 | PMC publication ID | 3661584 |
| P698 | PubMed publication ID | 23717409 |
| P5875 | ResearchGate publication ID | 236959493 |
| P50 | author | Janneke van de Wijgert | Q60433577 |
| Peter Reiss | Q92970863 | ||
| P2093 | author name string | Pascale Ondoa | |
| Odette Mukabayire | |||
| Hans Zaaijer | |||
| Kimberly R Boer | |||
| John Rusine | |||
| Brenda Asiimwe-Kateera | |||
| Julie Mugabekazi | |||
| Jean Marie Uwimana | |||
| P2860 | cites work | Global epidemiology of hepatitis C virus infection | Q27860799 |
| Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana | Q34120399 | ||
| Hepatitis C virus infection during pregnancy and the newborn period--are they opportunities for treatment? | Q34169767 | ||
| Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures | Q34302587 | ||
| HIV-HBV coinfection among South African patients receiving antiretroviral therapy | Q34401948 | ||
| Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South Africa | Q34468872 | ||
| Epidemiology of hepatitis B in Europe and worldwide | Q35621655 | ||
| Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation. | Q36075755 | ||
| HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms | Q36379622 | ||
| Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas | Q36504737 | ||
| Clinical implications of HIV and hepatitis B co-infection in Asia and Africa | Q36830375 | ||
| Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program | Q37161725 | ||
| Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria | Q37366842 | ||
| Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis | Q37792614 | ||
| Poor performance of hepatitis C antibody tests in hospital patients in Uganda | Q38872306 | ||
| Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda | Q38877392 | ||
| Hepatitis B virus and hiv infections among patients in Mulago hospital. | Q38883782 | ||
| Does immunological status affect the prevalence of Hepatitis C virus infection among HIV/AIDS patients? | Q39329075 | ||
| Preimmunization epidemiology of hepatitis B virus infection in South African children | Q39508435 | ||
| Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy. | Q39769341 | ||
| Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study). | Q42979089 | ||
| High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy | Q42989987 | ||
| Outcome of hepatitis C virus infection in Chinese paid plasma donors: a 12-19-year cohort study | Q43040026 | ||
| Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients | Q43644192 | ||
| Long-term safety of lamivudine treatment in patients with chronic hepatitis B. | Q44729211 | ||
| HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). | Q44933768 | ||
| Occult hepatitis B in HIV-infected patients | Q44949253 | ||
| Outcomes of starting first-line antiretroviral therapy in hepatitis B virus/HIV-coinfected patients in Ghana | Q45355330 | ||
| Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study | Q45395927 | ||
| Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons. | Q45401074 | ||
| Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy | Q45414035 | ||
| Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa | Q46519833 | ||
| HIV, hepatitis B and hepatitis C coinfection in Kenya | Q46558487 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Rwanda | Q1037 |
| seroprevalence | Q3511357 | ||
| P304 | page(s) | e63303 | |
| P577 | publication date | 2013-05-22 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda | |
| P478 | volume | 8 |
| Q36316465 | "Waiting for DAAs": A retrospective chart review of patients with untreated hepatitis C in Rwanda |
| Q30387567 | Association of Abnormal Liver Function Parameters with HIV Serostatus and CD4 Count in Antiretroviral-Naive Rwandan Women |
| Q35901466 | Combination Antiretroviral Therapy for HIV in Rwandan Adults: Clinical Outcomes and Impact on Reproductive Health up to 24 Months |
| Q40524606 | Epidemiological and clinical characteristics of hepatitis B virus in HIV-infected patients in Guangdong, China |
| Q40566052 | Epidemiological profile and risk factors of HIV and HBV/HCV co-infection in Fujian Province, southeastern China |
| Q35751678 | Geographic distribution of HCV genotypes in Libya and analysis of risk factors involved in their transmission |
| Q35775807 | Hepatitis B and C Co-Infections in Some HIV-Positive Populations in Cameroon, West Central Africa: Analysis of Samples Collected Over More Than a Decade |
| Q35061906 | Hepatitis B and C seroprevalence among health care workers in a tertiary hospital in Rwanda |
| Q92320991 | Hepatitis B virus seromarkers among HIV infected adults on ART: An unmet need for HBV screening in eastern Ethiopia |
| Q36241034 | Hepatitis B virus strains from Rwandan blood donors are genetically similar and form one clade within subgenotype A1. |
| Q35661832 | Hepatitis B, Hepatitis C and HIV-1 Coinfection in Two Informal Urban Settlements in Nairobi, Kenya |
| Q39400280 | Hepatitis C treatment outcomes using interferon- and ribavirin-based therapy in Kigali, Rwanda |
| Q30398982 | Hepatitis C virus and HIV co-infection among pregnant women in Rwanda |
| Q89970158 | Incidence of hepatitis B virus infection among human immunodeficiency virus-infected treatment naïve adults in Botswana |
| Q33439743 | Prevalence of Hepatitis C Virus Infection and Its Risk Factors among Patients Attending Rwanda Military Hospital, Rwanda |
| Q33630346 | Prevalence of hepatitis B and C infection in persons living with HIV enrolled in care in Rwanda |
| Q64067311 | Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda |
| Q99726439 | Prevalence, seroconversion and mother-to-child transmission of dual and triplex infections of HIV, hepatitis B and C viruses among pregnant women in Nigeria: study protocol |
| Q97525681 | Role of unsafe medical practices and sexual behaviours in the hepatitis B and C syndemic and HIV co-infection in Rwanda: a cross-sectional study |
| Q47552957 | Sero-prevalence of HBsAg in naive HIV-infected patients in a rural locality of Cameroon |
| Q64067307 | Sero-prevalence of hepatitis B and C viral infections in Ghanaian HIV positive cohort: a consideration for their health care |
| Q28539749 | Seroprevalence of HBV, HCV & HIV co-infection and risk factors analysis in Tripoli-Libya |
| Q46707355 | Seroprevalence of HBs Ag and of anti-HCV antibodies among HIV infected people in N'Djamena, Chad |
| Q40103857 | Syphilis and HIV prevalence and associated factors to their co-infection, hepatitis B and hepatitis C viruses prevalence among female sex workers in Rwanda |
| Q47242836 | The burden of hepatitis B virus (HBV) infection, genotypes and drug resistance mutations in human immunodeficiency virus-positive patients in Northwest Ethiopia. |
| Q41623032 | The prevalence of hepatitis B virus infection markers and socio-demographic risk factors in HIV-infected patients in Southern Brazil. |
| Q35641764 | Twelve-Month Antiretroviral Therapy Suppresses Plasma and Genital Viral Loads but Fails to Alter Genital Levels of Cytokines, in a Cohort of HIV-Infected Rwandan Women |
Search more.